http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#Head
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#provenance
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#pubinfo
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion
http://purl.obolibrary.org/obo/DOID_11247
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_11247
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00513
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
http://www.w3.org/2000/01/rdf-schema#label
"Aminocaproic Acid Tablets should not be used when there is evidence of an active intravascular clotting process. When there is uncertainty as to whether the cause of bleeding is primary fibrinolysis or disseminated intravascular coagulation (DIC), this distinction must be made before administering Aminocaproic Acid Tablets. The following tests can be applied to differentiate the two conditions: Platelet count is usually decreased in DIC but normal in primary fibrinolysis. Protamine paracoagulation test is positive in DIC; a precipitate forms when protamine sulfate is dropped into citrated plasma. The test is negative in the presence of primary fibrinolysis. The euglobulin clot lysis test is abnormal in primary fibrinolysis but normal in DIC. Aminocaproic Acid Tablets must not be used in the presence of DIC without concomitant heparin."
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00513
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#provenance
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#pubinfo
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig
http://purl.org/nanopub/x/hasSignature
ODGe7vGaGc3W9mi7TbXoKvYpzKS+Q8bRiCrpuCcamMOWqrv2gQLU31foEEtADxjwpfIJD/IKQHDirJGCrdt8xvx5T7tttGxX/TQ7Q+/gR02KH3maeJx1c9jyUXiRmal0gKWZAO5qkgGRBCvHHeofsrbWGHzioIxTmOlJhIovz5Q=
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://purl.org/dc/terms/created
2021-08-25T13:40:12.079+02:00
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY